The clinical application and research progression of glucagon-like-peptide-1

HIGHLIGHTS

• What: As a representative drug of GLP-1 RA, semaglutide has shown broad prospects in the treatment of diabetes, obesity and related field.
• Who: Ziyu Shu from the Wuxi Dipont School of Art and Science, Wuxi, China have published the research: The clinical application and research progression of glucagon- like-peptide-1, in the : Proceedings of ICBioMed 2024 Workshop: Computational Proteomics in Drug Discovery and Development from Medicinal Plants of January/16,/2024
• Future: Future research will focus more on individualized treatment strategies to achieve precision treatment by in-depth analysis of differences . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.